These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 811378)

  • 1. [Increase of immune response by administration of metabolizable vegetable oil emulsions].
    Audibert F; Chedid L
    C R Acad Hebd Seances Acad Sci D; 1975 Apr; 280(13):1629-32. PubMed ID: 811378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin E adjuvant formulations in mice.
    Tengerdy RP; Lacetera NG
    Vaccine; 1991 Mar; 9(3):204-6. PubMed ID: 2042393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the adjuvant effect of water-in-oil-in-water (w/o/w) emulsion of sesame oil. 1. Enhanced and persistent antibody formation by antigen incorporated into the water-in-oil-in-water emulsion.
    Kimura J; Nariuchi H; Watanabe T; Matuhasi T; Okayasu I; Hatakeyama S
    Jpn J Exp Med; 1978 Apr; 48(2):149-54. PubMed ID: 713123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of several adjuvant emulsion regimens for the production of polyclonal antisera in rabbits.
    Johnston BA; Eisen H; Fry D
    Lab Anim Sci; 1991 Jan; 41(1):15-21. PubMed ID: 1849580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable oil-in-water emulsions: preparation and use as vaccine vehicles for lipophilic adjuvants.
    Woodard LF; Jasman RL
    Vaccine; 1985 Jun; 3(2):137-44. PubMed ID: 4036272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of adjuvants on the immunological response of the chicken. I. Effects on primary and secondary responses of various adjuvants in the primary stimulus.
    Steinberg SV; Munro JA; Fleming WA; French VI; Stark JM; White RG
    Immunology; 1970 May; 18(5):635-44. PubMed ID: 4986929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of ethylene-vinyl acetate copolymer as a non-inflammatory alternative to Freund's complete adjuvant in rabbits.
    Niemi SM; Fox JG; Brown LR; Langer R
    Lab Anim Sci; 1985 Dec; 35(6):609-12. PubMed ID: 4094398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of thymus-dependent lymphocytes for potentiation by adjuvants of antibody formation.
    Allison AC; Davies AJ
    Nature; 1971 Oct; 233(5318):330-2. PubMed ID: 4940426
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant properties of Micropolyspora faeni.
    Bice DE; McCarron K; Hoffman EO; Salvaggio J
    Int Arch Allergy Appl Immunol; 1977; 55(1-6):267-74. PubMed ID: 338504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of adjuvants on the immunological response of the chicken. II. Effects of Freund's complete adjuvant on later antibody production after a single injection of immunogen.
    French VI; Stark JM; White RG
    Immunology; 1970 May; 18(5):645-55. PubMed ID: 4986930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the current status of oil adjuvants in foot--and--mouth disease vaccines.
    McKercher PD; Graves JH
    Dev Biol Stand; 1976; 35():107-12. PubMed ID: 198275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of adaptive immunity by different adjuvant-antigen combinations in mice lacking Nod2.
    Moreira LO; Smith AM; DeFreitas AA; Qualls JE; El Kasmi KC; Murray PJ
    Vaccine; 2008 Oct; 26(46):5808-13. PubMed ID: 18789992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15.
    Carvalho LV; Ruiz Rde C; Scaramuzzi K; Marengo EB; Matos JR; Tambourgi DV; Fantini MC; Sant'Anna OA
    Vaccine; 2010 Nov; 28(50):7829-36. PubMed ID: 20937318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New metabolizable immunologic adjuvant for human use. 5. Evaluation of highly purified influenza-virus vaccine in adjuvant 65.
    Weibel RE; Woodhour AF; Stokes J; Metzgar DP; Hilleman MR
    N Engl J Med; 1967 Jan; 276(2):78-84. PubMed ID: 6015520
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvanticity and strains of mycobacteria.
    Hiu IJ
    Jpn J Exp Med; 1980 Jun; 50(3):183-8. PubMed ID: 7001095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience in the United Kingdom with oil adjuvant influenza vaccines.
    Perkins FT
    Ann Allergy; 1972 May; 30(5):288-91. PubMed ID: 5063341
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the adjuvant activity of non-ionic surfactant vesicles: adjuvant-driven IgG2a production independent of MHC control.
    Brewer JM; Alexander J
    Vaccine; 1994 May; 12(7):613-9. PubMed ID: 8085378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the mechanism of the adjuvant effect of Bordetella pertussis vaccine.
    Reed CE; Benner M; Lockey SD; Enta T; Makino S; Carr RH
    J Allergy Clin Immunol; 1972 Mar; 49(3):174-82. PubMed ID: 5011091
    [No Abstract]   [Full Text] [Related]  

  • 19. O/W Nanoemulsion as an Adjuvant for an Inactivated H3N2 Influenza Vaccine: Based on Particle Properties and Mode of Carrying.
    Zhao L; Zhu Z; Ma L; Li Y
    Int J Nanomedicine; 2020; 15():2071-2083. PubMed ID: 32273703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and effect of different adjuvants on the immunogenic activity of mycobacterial ribosomal fraction.
    Youmans AS; Youmans GP
    J Bacteriol; 1967 Oct; 94(4):836-43. PubMed ID: 4963785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.